While the economic and scientific benefits of crossing borders are clear, multinational life sciences companies face logistical challenges when it comes to chemical management. Innovative software makes it easy to deal with these technical issues so that scientists can focus on maximizing the research benefits of multinational expansion.
Iced coffee has been around for a while and isn’t going anywhere, but more product refinement and improvement is sure to come over the next few years. And as competition within the iced coffee sector increases, focusing on bringing these new formulations and methods to market faster will be the key to gaining market advantage.
Magic sand was once hailed as an effective, environmentally friendly way to combat damage from oil spills but was abandoned due to expense. In light of new technological advancements, oil companies might want to start reconsidering magic sand as a tool for cleaning up oil spills.
With attention shifting to data integrity, companies must increasingly be able to guarantee the reliability and accuracy of their quality data. To do otherwise could leave companies vulnerable to data integrity and quality risks that increase their chances of noncompliance.
There are many different chemical ways of combating overdose, but researchers have identified three primary categories of biologic therapy for treating drug addiction and abuse: vaccines, monoclonal antibodies, and genetically modified enzymes.
Companies can prepare to compete with biosimilars by adopting a simple, yet effective, strategy: innovation. By developing drugs that improve upon earlier iterations, companies can continue to protect their market advantage from lower-cost generic versions.
There is a growing need for more efficacious retinal degenerative disease treatment as the population ages and there is mounting exposure to common causes.
These latest TSCA reform efforts reflect a current trend among federal agencies to increase regulatory oversight of commercial industries. Failing to comply with new standards can be costly and, in some cases, deadly.
Following the explosion of biomedical understanding over the last few decades, researchers have begun to develop biologic therapies for diseases. Understanding the biologics regulatory pathway will help researchers utilize emerging technology while ensuring that their new therapies meet necessary standards at every step of the process.
There is a growing body of research highlighting the unique properties of cancer stem cells and scientists can use this information to design biologic drugs that exploit CSC properties in order to provide more effective treatment strategies for cancer.